Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort)
- PMID: 22322085
- DOI: 10.1016/j.jacc.2011.11.011
Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort)
Abstract
Objectives: The purpose of this study was to determine whether the timing of the most recent cardiac implantable electronic device (CIED) procedure, either a permanent pacemaker or implantable cardioverter-defibrillator, influences the clinical presentation and outcome of lead-associated endocarditis (LAE).
Background: The CIED infection rate has increased at a time of increased device use. LAE is associated with significant morbidity and mortality.
Methods: The clinical presentation and course of LAE were evaluated by the MEDIC (Multicenter Electrophysiologic Device Cohort) registry, an international registry enrolling patients with CIED infection. Consecutive LAE patients enrolled in the Multicenter Electrophysiologic Device Cohort registry between January 2009 and May 2011 were analyzed. The clinical features and outcomes of 2 groups were compared based on the time from the most recent CIED procedure (early, <6 months; late, >6 months).
Results: The Multicenter Electrophysiologic Device Cohort registry entered 145 patients with LAE (early = 43, late = 102). Early LAE patients presented with signs and symptoms of local pocket infection, whereas a remote source of bacteremia was present in 38% of patients with late LAE but only 8% of early LAE (p < 0.01). Staphylococcal species were the most frequent pathogens in both early and late LAE. Treatment consisted of removal of all hardware and intravenous administration of antibiotics. In-hospital mortality was low (early = 7%, late = 6%).
Conclusions: The clinical presentation of LAE is influenced by the time from the most recent CIED procedure. Although clinical manifestations of pocket infection are present in the majority of patients with early LAE, late LAE should be considered in any CIED patient who presents with fever, bloodstream infection, or signs of sepsis, even if the device pocket appears uninfected. Prompt recognition and management may improve outcomes.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry.JACC Cardiovasc Imaging. 2014 Jun;7(6):541-9. doi: 10.1016/j.jcmg.2014.01.015. Epub 2014 May 7. JACC Cardiovasc Imaging. 2014. PMID: 24813965
-
Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections.Pacing Clin Electrophysiol. 2014 Aug;37(8):955-62. doi: 10.1111/pace.12385. Epub 2014 Mar 25. Pacing Clin Electrophysiol. 2014. PMID: 24665867
-
Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.Heart. 2012 May;98(9):724-31. doi: 10.1136/heartjnl-2012-301627. Heart. 2012. PMID: 22523057
-
[Non-valvular cardiac devices endocarditis].Ann Cardiol Angeiol (Paris). 2008 Apr;57(2):81-7. doi: 10.1016/j.ancard.2008.02.005. Epub 2008 Mar 18. Ann Cardiol Angeiol (Paris). 2008. PMID: 18402924 Review. French.
-
Management of bacteremia in patients living with cardiovascular implantable electronic devices.Heart Rhythm. 2016 Nov;13(11):2247-2252. doi: 10.1016/j.hrthm.2016.08.029. Epub 2016 Aug 19. Heart Rhythm. 2016. PMID: 27546815 Review.
Cited by
-
Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).Circ Arrhythm Electrophysiol. 2015 Feb;8(1):137-44. doi: 10.1161/CIRCEP.114.002199. Epub 2014 Dec 12. Circ Arrhythm Electrophysiol. 2015. PMID: 25504648 Free PMC article.
-
Cardiovascular Implantable Electronic Device Infection and New Insights About Correlation Between Pro-inflammatory Markers and Heart Failure: A Systematic Literature Review and Meta-Analysis.Front Cardiovasc Med. 2021 May 3;8:602275. doi: 10.3389/fcvm.2021.602275. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34012983 Free PMC article.
-
Incidence and Predictors of Implantable Cardioverter-defibrillator Therapies After Generator Replacement-A Pooled Analysis of 31,640 Patients' Data.J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5278-5293. doi: 10.19102/icrm.2022.13121. eCollection 2022 Dec. J Innov Card Rhythm Manag. 2022. PMID: 37293556 Free PMC article.
-
Prevention, Diagnosis, and Treatment of Cardiac Implantable Electronic Device Infections.Curr Cardiol Rep. 2016 Jun;18(6):58. doi: 10.1007/s11886-016-0733-x. Curr Cardiol Rep. 2016. PMID: 27147510 Review.
-
Current trends in the management of cardiac implantable electronic device (CIED) infections.Intern Emerg Med. 2013 Sep;8(6):465-76. doi: 10.1007/s11739-012-0797-6. Epub 2012 Jun 29. Intern Emerg Med. 2013. PMID: 22744804 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical